Do novel antipsychotics improve cognition? A report of a meta-analysis

Psychiatric Annals

Volumn 29, Issue 11, 1999, Pages 623-629

  Keefe, Richard S E ^a   Bollini, Anna M ^a   Silva, Susan G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 6244306456     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19991101-08     Document Type: Article

References (25)

1. Green MF, Marshall BD, Wirshing WC Jr, et al. Does risperidone improve working memory in treatment-resistant schizophrenia? Am J Psychiatry. 1997;154:799-804.
2. Blyler CR, Gold JM. Cognitive effects of typical antipsychotic treatment: another look. In: Sharma T, Harvey PD, eds. Cognitive Deficits in Schizophrenia. Oxford: Oxford University Press. In press.
3. Keefe RSE, Gold JM. Comparing pharmacologic strategies of improving cognition. In: Keefe RSE, ed. Improving Cognitive Function in Schizophrenia. London: Science Press. In press.
4. Stip E. Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy. Can J Psychiatry. 1996;41(suppl 2):27S-34S.
5. Peretti CS, Danion JM, Kauffmann-Muller F, Grange D, Patat A, Rosenzweig P. Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers. Psychopharmacology (Berl). 1997;131:329-338.
6. Keefe RSE, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull. 1999;25:201-222..
7. Meyer-Lindenberg A, Gruppe H, Bauer U, Lis S, Krieger S, Gallhofer B. Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study. Pharmacopsychiatry. 1997;30:35-42.
8. Buchanan RW, Holstein C, Brier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry. 1994;6:717-725.
9. McGurk SR, Green MF, Wirshing WC, et al. The effects of risperidone vs haloperidol on cognitive functioning in treatment-resistant schizophrenia: the trial making test. CNS Spectrums. 1997;2:60-64.
10. Kern RS, Green MF, Marshall BD Jr, et al. Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenic patients. Biol Psychiatry. 1999;44:726-732.
11. Goldberg TE, Greenberg RD, Griffin SJ, et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry. 1993;162:43-48.
12. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry. 1993;34:702-712.
13. Lee MA, Thompson PA, Meltzer HY. Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry. 1994;55(suppl B):82-87.
14. Zahn TP, Pickar D, Haier RJ. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophr Res. 1994;13:133-144.
15. Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H. Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol. 1996;6(suppl 2):13-20.
16. Hoff AL, Faustman WO, Wieneke M, et al. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacology. 1996;15:361-369.
17. Stip E, Lussier I. The effect of risperidone on cognition in patients with schizophrenia. Can J Psychiatry. 1996; 41(suppl 2):35-40.
18. Rossi A, Mancini F, Stratta P, et al. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study. Acta Psychiatr Scand. 1997;95:40-43.
19. Serper MR, Chou JCY. Novel neuroleptics improve attentional functioning in schizophrenic patients: ziprazidone and aripiprazole. CNS Spectrums. 1997;2:56-59.
20. Galletly CA, Clark RC, McFarlane AC, Weber DL. The relationship between changes in symptom ratings, neuropsychological test performance, and quality of life in schizophrenic patients treated with clozapine. Psychiatry Res. 1997;72:161-166.
21. Fujii DEM, Ahmed I, Jokumsen M, Compton JM. The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients. J Neuropsychiatry Clin Neurosci. 1997;9:240-245.
22. Sax KW, Strakowski SM, Keck PE Jr. Attentional improvement following quetiapine fumarate treatment in schizophrenia. Schizophr Res. 1998;33:151-155.
23. Stip E, Lussier I, Babai M, Fabian JL, Link C. Seroquel and cognitive improvement in patients with schizophrenia. Biol Psychiatry. 1996;40:434-435. Letter.
24. Meltzer HY, McGurk SR. The effect of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull. 1999;25:233-255.
25. Rosenheck R, Cramer J, Xu W, et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia: Department of Veterans' Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med. 1997;337:809-815.